Saturna Capital Corp Amgen Inc Transaction History

Saturna Capital Corp

$7.5 Billion
Q3 2024

A detailed history of Saturna Capital Corp transactions in Amgen Inc stock. As of the latest transaction made, Saturna Capital Corp holds 139,097 shares of AMGN stock, worth $36.6 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares

139,097

Previous 141,262 1.53%

Holding current value

$36.6 Million

Previous $44.1 Million 1.54%

% of portfolio

0.6%

Previous 0.59%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$309.38 - $337.38 $669,807 - $730,427	-2,165 Reduced 1.53%	139,097 $44.8 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $84.8 Million - $103 Million	-322,705 Reduced 69.55%	141,262 $44.1 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $2.43 Million - $2.74 Million	-9,515 Reduced 2.01%	463,967 $134 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $4.62 Million - $5.74 Million	-21,140 Reduced 4.27%	473,482 $127 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $1.24 Million - $1.47 Million	-5,806 Reduced 1.16%	494,622 $110 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $7.9 Million - $9.63 Million	35,000 Added 7.52%	500,428 $121 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $25,651 - $32,593	-112 Reduced 0.02%	465,428 $122 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $23.8 Million - $26.9 Million	106,112 Added 29.52%	465,540 $105 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $12,059 - $13,341	55 Added 0.02%	359,428 $86.9 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $133,846 - $153,174	-673 Reduced 0.19%	359,373 $80.8 Million
Q3 2021 Nov 08, 2021	BUY	$212.27 - $248.7 $42,454 - $49,740	200 Added 0.06%	360,046 $73.2 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $87,592 - $97,177	-375 Reduced 0.1%	359,846 $87.7 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $6,879 - $8,016	-31 Reduced 0.01%	360,221 $89.6 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $23,801 - $28,343	-110 Reduced 0.03%	360,252 $82.8 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $3,784 - $4,864	-20 Reduced 0.01%	360,362 $86.9 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $32,732 - $39,220	-188 Reduced 0.05%	360,382 $69.7 Million
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $312,729 - $366,589	-1,876 Reduced 0.52%	360,570 $66.4 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $115,575 - $130,279	-639 Reduced 0.18%	362,446 $68.9 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $70,239 - $78,893	-423 Reduced 0.12%	363,085 $67 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $220,767 - $257,994	-1,303 Reduced 0.36%	363,508 $62 Million
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $49,286 - $55,068	292 Added 0.08%	364,811 $63.4 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $108,403 - $123,768	648 Added 0.18%	364,519 $67.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	363,871	363,871 $62.7 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Amgen Inc Transaction History